These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1235002)

  • 1. Problems in the treatment of slow-growing tumors.
    Van Putten LM
    Recent Results Cancer Res; 1975; (52):225-33. PubMed ID: 1235002
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of cell kinetics in the development of drug combinations.
    Valeriote FA
    Pharmacol Ther; 1979; 4(1):1-33. PubMed ID: 461499
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cell kinetics in cancer chemotherapy.
    Valeriote FA; Edelstein MB
    Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
    [No Abstract]   [Full Text] [Related]  

  • 4. KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.
    Bumol TF; Baker AL; Andrews EL; DeHerdt SV; Briggs SL; Spearman ME; Apelgren LD
    Targeted Diagn Ther; 1988; 1():55-79. PubMed ID: 2979063
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy--theory and practice.
    Capizzi RL; Keiser LW; Sartorelli AC
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.
    Rowinsky EK; Donehower RC
    Pharmacol Ther; 1991 Oct; 52(1):35-84. PubMed ID: 1687171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of chemotherapy on the morphology of solid tumours.
    Cooper EH
    Schweiz Med Wochenschr; 1974 Feb; 104(8):275-8. PubMed ID: 4814679
    [No Abstract]   [Full Text] [Related]  

  • 8. A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.
    Kim M; Woo KB; Perry S
    Ann Biomed Eng; 1977 Mar; 5(1):12-33. PubMed ID: 557938
    [No Abstract]   [Full Text] [Related]  

  • 9. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
    Ono M; Tanaka N
    In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead.
    Martino E; Casamassima G; Castiglione S; Cellupica E; Pantalone S; Papagni F; Rui M; Siciliano AM; Collina S
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2816-2826. PubMed ID: 30122223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.
    Sweeney MJ; Boder GB; Cullinan GJ; Culp HW; Daniels WD; Dyke RW; Gerzon K; McMahon RE; Nelson RL; Poore GA; Todd GC
    Cancer Res; 1978 Sep; 38(9):2886-91. PubMed ID: 679195
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytocidal action of anticancer antigens: evaluation of the sensitivity of cultured animal and human cancer cells.
    Shimoyama M
    Bibl Haematol; 1975; (40):711-22. PubMed ID: 169835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplasia, kinetics, nd chemotherapy.
    Hart JS; Livingston RB; Murphy WK; Barlogie B; Gehan EA; Bodey GP
    Semin Oncol; 1976 Sep; 3(3):259-70. PubMed ID: 790580
    [No Abstract]   [Full Text] [Related]  

  • 14. Implications of certain cell kinetic and biological parameters for preoperative chemotherapy.
    Hill BT
    Recent Results Cancer Res; 1986; 103():41-53. PubMed ID: 3526475
    [No Abstract]   [Full Text] [Related]  

  • 15. The cell cycle and its significance for cancer treatment.
    Hill BT; Baserga R
    Cancer Treat Rev; 1975 Sep; 2(3):159-75. PubMed ID: 1104161
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
    Reddy JA; Dorton R; Bloomfield A; Nelson M; Vetzel M; Guan J; Leamon CP
    Clin Cancer Res; 2014 Apr; 20(8):2104-14. PubMed ID: 24429878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of cytostatics on proliferating and stationary cultures of mammalian cells.
    Olah E; Palyi I; Sugar J
    Eur J Cancer (1965); 1978 Aug; 14(8):895-900. PubMed ID: 80320
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxicity, cell cycle kinetics and morphonuclear-induced effects of Vinca alkaloid anticancer agents.
    Pauwels O; Kiss R; Pasteels JL; Atassi G
    J Pharm Pharmacol; 1995 Oct; 47(10):870-5. PubMed ID: 8583358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative character and growth modes of neoplastic disease as determinants of chemotherapeutic efficacy.
    Schenken LL
    Cancer Treat Rep; 1976 Dec; 60(12):1761-76. PubMed ID: 829040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.